A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

Miguela A, Huertas-Pons J M, Coll-Martinez C, Gifreu-Fraixinó A, Salavedra-Pont J, Comabella M, Villar L M, Gich J, Álvarez-Bravo G, Ramió-Torrentà L, et al.